• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于临床病理危险因素和术前MRI影像组学的决策树模型在预测胶质母细胞瘤全切术后短期复发中的应用:一项回顾性队列研究

The application of decision tree model based on clinicopathological risk factors and pre-operative MRI radiomics for predicting short-term recurrence of glioblastoma after total resection: a retrospective cohort study.

作者信息

Du Peng, Wu Xuefan, Liu Xiao, Chen Jiawei, Chen Lang, Cao Aihong, Geng Daoying

机构信息

Department of Radiology, Huashan Hospital, Fudan University Shanghai 200040, China.

Department of Radiology, The Second Affiliated Hospital of Xuzhou Medical University Xuzhou 221000, Jiangsu, China.

出版信息

Am J Cancer Res. 2023 Aug 15;13(8):3449-3462. eCollection 2023.

PMID:37693142
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10492119/
Abstract

To develop a decision tree model based on clinical information, molecular genetics information and pre-operative magnetic resonance imaging (MRI) radiomics-score (Rad-score) to investigate its predictive value for the risk of recurrence of glioblastoma (GBM) within one year after total resection. Patients with pathologically confirmed GBM at Huashan Hospital, Fudan University between November 2017 and June 2020 were retrospectively analyzed, and the enrolled patients were randomly divided into training and test sets according to the ratio of 3:1. The relevant clinical and MRI data of patients before, after surgery and follow-up were collected, and after feature extraction on preoperative MRI, the LASSO filter was used to filter the features and establish the Rad-score. Using the training set, a decision tree model for predicting recurrence of GBM within one year after total resection was established by the C5.0 algorithm, and scatter plots were generated to evaluate the prediction accuracy of the decision tree during model testing. The prediction performance of the model was also evaluated by calculating area under the receiver operating characteristic (ROC) curve (AUC), ACC, Sensitivity (SEN), Specificity (SPE) and other indicators. Besides, two external validation datasets from Wuhan union hospital and the second affiliated hospital of Xuzhou Medical University were used to verify the reliability and accuracy of the prediction model. According to the inclusion and exclusion criteria, 134 patients with GBM were finally identified for inclusion in the study, and 53 patients recurred within one year after total resection, with a mean recurrence time of 5.6 months. According to the importance of the predictor variables, a decision tree model for predicting recurrence based on five important factors, including patient age, Rad-score, O-methylguanine-DNA methyltransferase (MGMT) promoter methylation, pre-operative Karnofsky Performance Status (KPS) and Telomerase reverse transcriptase (TERT) promoter mutation, was developed. The AUCs of the model in the training and test sets were 0.850 and 0.719, respectively, and the scatter plot showed excellent consistency. In addition, the prediction model achieved AUCs of 0.810 and 0.702 in two external validation datasets from Wuhan union hospital and the second affiliated hospital of Xuzhou Medical University, respectively. The decision tree model based on clinicopathological risk factors and preoperative MRI Rad-score can accurately predict the risk of recurrence of GBM within one year after total resection, which can further guide the clinical optimization of patient treatment decisions, as well as refine the clinical management of patients and improve their prognoses to a certain extent.

摘要

基于临床信息、分子遗传学信息和术前磁共振成像(MRI)影像组学评分(Rad-score)构建决策树模型,以研究其对胶质母细胞瘤(GBM)全切除术后一年内复发风险的预测价值。回顾性分析2017年11月至2020年6月在复旦大学附属华山医院经病理确诊为GBM的患者,并根据3:1的比例将纳入患者随机分为训练集和测试集。收集患者手术前后及随访的相关临床和MRI数据,对术前MRI进行特征提取后,采用LASSO滤波器筛选特征并建立Rad-score。利用训练集,通过C5.0算法建立预测GBM全切除术后一年内复发的决策树模型,并生成散点图评估模型测试期间决策树的预测准确性。还通过计算受试者操作特征(ROC)曲线下面积(AUC)、ACC、灵敏度(SEN)、特异性(SPE)等指标评估模型的预测性能。此外,使用来自武汉协和医院和徐州医科大学第二附属医院的两个外部验证数据集验证预测模型的可靠性和准确性。根据纳入和排除标准,最终确定134例GBM患者纳入研究,其中53例在全切除术后一年内复发,平均复发时间为5.6个月。根据预测变量的重要性,构建了基于患者年龄、Rad-score、O-甲基鸟嘌呤-DNA甲基转移酶(MGMT)启动子甲基化、术前卡氏评分(KPS)和端粒酶逆转录酶(TERT)启动子突变这五个重要因素的复发预测决策树模型。该模型在训练集和测试集的AUC分别为0.850和0.719,散点图显示出良好的一致性。此外,该预测模型在来自武汉协和医院和徐州医科大学第二附属医院的两个外部验证数据集中的AUC分别为0.810和0.702。基于临床病理危险因素和术前MRI Rad-score的决策树模型能够准确预测GBM全切除术后一年内的复发风险,可进一步指导临床优化患者治疗决策,在一定程度上细化患者的临床管理并改善其预后。

相似文献

1
The application of decision tree model based on clinicopathological risk factors and pre-operative MRI radiomics for predicting short-term recurrence of glioblastoma after total resection: a retrospective cohort study.基于临床病理危险因素和术前MRI影像组学的决策树模型在预测胶质母细胞瘤全切术后短期复发中的应用:一项回顾性队列研究
Am J Cancer Res. 2023 Aug 15;13(8):3449-3462. eCollection 2023.
2
Establishment of a Prediction Model Based on Preoperative MRI Radiomics for Diffuse Astrocytic Glioma, IDH-Wildtype, with Molecular Features of Glioblastoma.基于术前MRI影像组学建立弥漫性星形细胞瘤(IDH野生型,具有胶质母细胞瘤分子特征)的预测模型
Cancers (Basel). 2023 Oct 21;15(20):5094. doi: 10.3390/cancers15205094.
3
Multi-parameter MRI based radiomics nomogram for predicting telomerase reverse transcriptase promoter mutation and prognosis in glioblastoma.基于多参数磁共振成像的影像组学列线图预测胶质母细胞瘤中端粒酶逆转录酶启动子突变及预后
Front Neurol. 2023 Sep 26;14:1266658. doi: 10.3389/fneur.2023.1266658. eCollection 2023.
4
A radiomics-based nomogram may be useful for predicting telomerase reverse transcriptase promoter mutation status in adult glioblastoma.基于放射组学的列线图可能有助于预测成人胶质母细胞瘤中端粒酶逆转录酶启动子突变状态。
Brain Behav. 2024 May;14(5):e3528. doi: 10.1002/brb3.3528.
5
Prediction of recurrence of ischemic stroke within 1 year of discharge based on machine learning MRI radiomics.基于机器学习MRI影像组学对缺血性卒中出院后1年内复发的预测
Front Neurosci. 2023 May 4;17:1110579. doi: 10.3389/fnins.2023.1110579. eCollection 2023.
6
Preoperative Prediction of Lymph Node Metastasis of Pancreatic Ductal Adenocarcinoma Based on a Radiomics Nomogram of Dual-Parametric MRI Imaging.基于双参数MRI成像的影像组学列线图对胰腺导管腺癌淋巴结转移的术前预测
Front Oncol. 2022 Jul 6;12:927077. doi: 10.3389/fonc.2022.927077. eCollection 2022.
7
Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study.磁共振成像放射组学预测术前腋窝淋巴结转移以支持手术决策,并与浸润性乳腺癌的肿瘤微环境相关:一项机器学习、多中心研究。
EBioMedicine. 2021 Jul;69:103460. doi: 10.1016/j.ebiom.2021.103460. Epub 2021 Jul 4.
8
Radiomics features based on automatic segmented MRI images: Prognostic biomarkers for triple-negative breast cancer treated with neoadjuvant chemotherapy.基于自动分割 MRI 图像的放射组学特征:新辅助化疗治疗三阴性乳腺癌的预后生物标志物。
Eur J Radiol. 2022 Jan;146:110095. doi: 10.1016/j.ejrad.2021.110095. Epub 2021 Dec 4.
9
Noninvasive O Methylguanine-DNA Methyltransferase Status Prediction in Glioblastoma Multiforme Cancer Using Magnetic Resonance Imaging Radiomics Features: Univariate and Multivariate Radiogenomics Analysis.使用磁共振成像放射组学特征无创性 O6-甲基鸟嘌呤-DNA 甲基转移酶状态预测多形性胶质母细胞瘤:单变量和多变量放射基因组学分析。
World Neurosurg. 2019 Dec;132:e140-e161. doi: 10.1016/j.wneu.2019.08.232. Epub 2019 Sep 7.
10
Development and validation of a multi-modality fusion deep learning model for differentiating glioblastoma from solitary brain metastases.开发和验证一种多模态融合深度学习模型,用于区分胶质母细胞瘤和单发脑转移瘤。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024 Jan 28;49(1):58-67. doi: 10.11817/j.issn.1672-7347.2024.230248.

引用本文的文献

1
A deep learning model to predict glioma recurrence using integrated genomic and clinical data.一种利用整合的基因组和临床数据预测神经胶质瘤复发的深度学习模型。
Commun Med (Lond). 2025 Aug 19;5(1):359. doi: 10.1038/s43856-025-01083-3.
2
Enhancement of the nontumor component in newly diagnosed glioblastoma as a more accurate predictor of local recurrence location: a multicenter study.新诊断胶质母细胞瘤中非肿瘤成分增强作为局部复发位置更准确预测指标的多中心研究
Quant Imaging Med Surg. 2025 Jan 2;15(1):299-313. doi: 10.21037/qims-24-1319. Epub 2024 Dec 24.

本文引用的文献

1
Clinical management and survival outcomes of patients with different molecular subtypes of diffuse gliomas in China (2011-2017): a multicenter retrospective study from CGGA.中国弥漫性神经胶质瘤不同分子亚型患者的临床管理和生存结局(2011-2017):来自 CGGA 的一项多中心回顾性研究。
Cancer Biol Med. 2022 Nov 1;19(10):1460-76. doi: 10.20892/j.issn.2095-3941.2022.0469.
2
Processing Decision Tree Data Using Internet of Things (IoT) and Artificial Intelligence Technologies with Special Reference to Medical Application.利用物联网 (IoT) 和人工智能技术处理决策树数据,特别参考医疗应用。
Biomed Res Int. 2022 Jun 28;2022:8626234. doi: 10.1155/2022/8626234. eCollection 2022.
3
Glioma targeted therapy: insight into future of molecular approaches.脑胶质瘤靶向治疗:分子靶向治疗的未来展望。
Mol Cancer. 2022 Feb 8;21(1):39. doi: 10.1186/s12943-022-01513-z.
4
Survival impact of delaying postoperative chemoradiotherapy in newly-diagnosed glioblastoma patients.新诊断胶质母细胞瘤患者延迟术后放化疗对生存的影响。
Transl Cancer Res. 2020 Sep;9(9):5450-5458. doi: 10.21037/tcr-20-1718.
5
Independently validated sex-specific nomograms for predicting survival in patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825.独立验证的新诊断胶质母细胞瘤患者生存预测的性别特异性列线图:NRG 肿瘤学 RTOG 0525 和 0825。
J Neurooncol. 2021 Dec;155(3):363-372. doi: 10.1007/s11060-021-03886-5. Epub 2021 Nov 10.
6
The prognosis of glioblastoma: a large, multifactorial study.胶质母细胞瘤的预后:一项大型多因素研究。
Br J Neurosurg. 2021 Oct;35(5):555-561. doi: 10.1080/02688697.2021.1907306. Epub 2021 Jul 8.
7
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.2021 年世卫组织中枢神经系统肿瘤分类:概述。
Neuro Oncol. 2021 Aug 2;23(8):1231-1251. doi: 10.1093/neuonc/noab106.
8
A decision tree model for neuroimmune guidance of allergic immunity.神经免疫指导过敏免疫的决策树模型。
Immunol Cell Biol. 2021 Oct;99(9):936-948. doi: 10.1111/imcb.12486. Epub 2021 Jun 28.
9
Evidence-based recommendations on categories for extent of resection in diffuse glioma.弥漫性胶质瘤切除范围分类的循证医学建议。
Eur J Cancer. 2021 May;149:23-33. doi: 10.1016/j.ejca.2021.03.002. Epub 2021 Apr 2.
10
A Nomogram Predicts Individual Prognosis in Patients With Newly Diagnosed Glioblastoma by Integrating the Extent of Resection of Non-Enhancing Tumors.一种列线图通过整合非增强肿瘤的切除范围来预测新诊断胶质母细胞瘤患者的个体预后。
Front Oncol. 2020 Dec 2;10:598965. doi: 10.3389/fonc.2020.598965. eCollection 2020.